Our study shows that inhibiting USP14 expression or its function leads to cell proliferation inhibition and cell cycle arrest at the G0/G1 phase in androgen-responsive prostate cancer cells but not in androgen-irresponsive prostate cancer cells. Here, USP14 is linked to prostate cancer.